Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sarnelli

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE ProjectValentina Di Iorio, Anna Sarnelli, Stefano Boschi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumorsSilvia Nicolini, Lisa Bodei, Alberto Bongiovanni, et al.
Journal of Visualized Experiments : Jove|May 12, 2020
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image MethodsMaria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, et al.
Frontiers in Oncology|April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade GliomaDonatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II studyIrene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
Biomed Research International|April 8, 2020
Cauliflower Mosaic Virus TAV, a Plant Virus Protein That Functions like Ribonuclease H1 and is Cytotoxic to Glioma CellsValentina Turri, Olga S Latinovic, Massimiliano Bonafè, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 6, 2021
TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancerAnna Tesei, Chiara Arienti, Gianluca Bossi, et al.
Cell Death and Differentiation|January 10, 2019
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenariansGianluca Storci, Sabrina De Carolis, Alessio Papi, et al.
Tumori|February 18, 2015
Twenty years of radiobiology in clinical practice: the Italian contributionLidia Strigari, Rocchina Caivano, Michele Avanzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-upStefano Severi, Ilaria Grassi, Alberto Bongiovanni, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE ProjectValentina Di Iorio, Anna Sarnelli, Stefano Boschi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumorsSilvia Nicolini, Lisa Bodei, Alberto Bongiovanni, et al.
Journal of Visualized Experiments : Jove|May 12, 2020
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image MethodsMaria Luisa Belli, Emilio Mezzenga, Valentina Di Iorio, et al.
Frontiers in Oncology|April 16, 2021
Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade GliomaDonatella Arpa, Elisabetta Parisi, Giulia Ghigi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II studyIrene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
Biomed Research International|April 8, 2020
Cauliflower Mosaic Virus TAV, a Plant Virus Protein That Functions like Ribonuclease H1 and is Cytotoxic to Glioma CellsValentina Turri, Olga S Latinovic, Massimiliano Bonafè, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 6, 2021
TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancerAnna Tesei, Chiara Arienti, Gianluca Bossi, et al.
Cell Death and Differentiation|January 10, 2019
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenariansGianluca Storci, Sabrina De Carolis, Alessio Papi, et al.
Tumori|February 18, 2015
Twenty years of radiobiology in clinical practice: the Italian contributionLidia Strigari, Rocchina Caivano, Michele Avanzo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-upStefano Severi, Ilaria Grassi, Alberto Bongiovanni, et al.
Pageof 7